Nothing Special   »   [go: up one dir, main page]

AU3419793A - Method of diagnosing combined cognitive/debilatory disorders - Google Patents

Method of diagnosing combined cognitive/debilatory disorders

Info

Publication number
AU3419793A
AU3419793A AU34197/93A AU3419793A AU3419793A AU 3419793 A AU3419793 A AU 3419793A AU 34197/93 A AU34197/93 A AU 34197/93A AU 3419793 A AU3419793 A AU 3419793A AU 3419793 A AU3419793 A AU 3419793A
Authority
AU
Australia
Prior art keywords
debilatory
diagnosing
disorders
combined cognitive
cognitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34197/93A
Inventor
William A. Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEM Pharmaceuticals Corp
Original Assignee
HEM Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEM Pharmaceuticals Corp filed Critical HEM Pharmaceuticals Corp
Publication of AU3419793A publication Critical patent/AU3419793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU34197/93A 1991-12-23 1992-12-23 Method of diagnosing combined cognitive/debilatory disorders Abandoned AU3419793A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81143291A 1991-12-23 1991-12-23
US811432 1991-12-23

Publications (1)

Publication Number Publication Date
AU3419793A true AU3419793A (en) 1993-07-28

Family

ID=25206543

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34197/93A Abandoned AU3419793A (en) 1991-12-23 1992-12-23 Method of diagnosing combined cognitive/debilatory disorders

Country Status (4)

Country Link
CN (1) CN1074537A (en)
AU (1) AU3419793A (en)
WO (1) WO1993013419A1 (en)
ZA (1) ZA929945B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU766635B2 (en) * 1999-09-24 2003-10-23 Smithkline Beecham Biologicals (Sa) Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1335203A3 (en) * 2002-02-09 2004-03-17 Wilfried P. Bieger Method and kit for determining neuroimmunological health disorders
DE202010004193U1 (en) 2010-03-22 2011-05-05 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Test kits for the determination of neuroregulatory and mental disorders
DE102011005878A1 (en) 2010-03-22 2011-12-01 Wilfried P. Bieger Determining neuromodulatory or mental disorders using arrangements for liquid chromatography, comprises measuring concentrations of neurotransmitters in blood cells and carrying out concentration measurements in thrombocytes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU766635B2 (en) * 1999-09-24 2003-10-23 Smithkline Beecham Biologicals (Sa) Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant

Also Published As

Publication number Publication date
CN1074537A (en) 1993-07-21
ZA929945B (en) 1993-08-02
WO1993013419A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
AU3602693A (en) Diagnosing brain conditions by quantitative electroencephalography
AU4160396A (en) Method for diagnosis of thrombotic disorders
AU4670293A (en) Non-invasive testing
AU1994495A (en) Method of analyzing sleep disorders
AU4237896A (en) Method and intermediates for the synthesis of korupensamines
AU4013193A (en) Method of maintaining relationships between elements
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
AUPN205095A0 (en) Diagnosis of neuromuscular dysfunction
PL336149A1 (en) Method of diagnosing psychiatric disorders
AU2377095A (en) Apparatus for the manufacture of innerspring constructions
AU3813289A (en) Treatment of gastrointestinal disorders
AU7992994A (en) Immunoassay for the dectection of human autoantibodies
AU8156094A (en) Methods of inhibiting breast disorders
EP0727959A4 (en) Diagnostic uses of hydrazinoadenosines
AU3419793A (en) Method of diagnosing combined cognitive/debilatory disorders
AU5518694A (en) Treatment of a group of related disorders
AU3431593A (en) Method of diagnosing combined cognitive/debilatory disorders
AU5430894A (en) Diagnosis of eye disorders
AU7201696A (en) Method of diagnosing crohn's disease
AU4602996A (en) Remote summoning of elevators
PL293281A1 (en) Method of obtaining novel 3-amino syndoimines
IL107515A0 (en) Diagnosis of mental disorders
RU2003311C1 (en) Method of blepharorrhaphy
AU7454594A (en) Treatment of anorectal disorders
AUPM424794A0 (en) Treatment of anorectal disorders